Immunotherapy May Extend Survival in Prostate Cancer Patients

Share this content:

A new prostate cancer treatment derived from immune cells taken from a prostate cancer patient may extend survival. John Schieszer has the latest in today's Medical Minute
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters